Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating with the Joint Institute for Nuclear Research (JINR), an international intergovernmental scientific organization established by eleven founding...
MedMira Inc. announces the expansion of its VYRA product line by launching its VYRA CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s...
Valneva SE ,a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The...
IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, announces that IMCD Australia & New Zealand have signed an agreement...
Novartis announced that it entered into a definitive agreement to acquire all of the outstanding share capital of the UK-based ocular gene therapy company...
